| Date | Company Name | Action | Current
Price | Price
Target | Rating | Impact on
Share Price |
|---|
| 6/17/2021 | BPMC Blueprint Medicines | Boost Price Target | $83.00 | $127.00 ➝ $137.00 | Outperform | Low |
| 6/16/2021 | SAGE Sage Therapeutics | Lower Price Target | $55.00 | $90.00 ➝ $70.00 | Market Perform | High |
| 6/15/2021 | EQ Equillium | Reiterated Rating | $6.00 | | Buy | Low |
| 6/15/2021 | INCY Incyte | Reiterated Rating | $83.00 | | Sell | Low |
| 6/15/2021 | XLRN Acceleron Pharma | Reiterated Rating | $127.00 | | Hold | High |
| 6/14/2021 | ASND Ascendis Pharma A/S | Lower Price Target | $138.00 | $191.00 ➝ $181.00 | Positive ➝ Outperform | High |
| 6/14/2021 | VRTX Vertex Pharmaceuticals | Lower Price Target | $188.00 | $250.00 ➝ $200.00 | Reduce ➝ Market Perform | Low |
| 6/14/2021 | BGNE BeiGene | Boost Price Target | $330.00 | $388.00 ➝ $417.00 | Positive ➝ Outperform | Low |
| 6/13/2021 | ETNB 89bio | Reiterated Rating | $19.00 | | Buy | Medium |
| 6/11/2021 | FMTX Forma Therapeutics | Lower Price Target | $25.00 | $65.00 ➝ $54.00 | Outperform | High |
| 6/10/2021 | FOLD Amicus Therapeutics | Reiterated Rating | $10.00 | | Hold | High |
| 6/10/2021 | BLUE bluebird bio | Initiated Coverage | $33.00 | | Buy | Medium |
| 6/10/2021 | QTRX Quanterix | Reiterated Rating | $65.00 | | Buy | High |
| 6/10/2021 | BIIB Biogen | Boost Price Target | $384.00 | $380.00 ➝ $475.00 | Outperform | Medium |
| 6/7/2021 | AMGN Amgen | Boost Price Target | $241.00 | $230.00 ➝ $238.00 | Market Perform | Low |
| 6/6/2021 | TVTX Travere Therapeutics | Reiterated Rating | $15.00 | | Buy | Low |
| 6/6/2021 | OLK Olink Holding AB (publ) | Reiterated Rating | $31.00 | | Buy | Medium |
| 6/6/2021 | PHR Phreesia | Reiterated Rating | $58.00 | | Buy | High |
| 6/6/2021 | ABMD Abiomed | Reiterated Rating | $313.00 | | Hold | Low |
| 6/4/2021 | CGEM Cullinan Oncology | Boost Price Target | $26.00 | $48.00 ➝ $54.00 | Outperform | High |
| 6/4/2021 | AZN AstraZeneca | Boost Price Target | $58.00 | $63.00 ➝ $64.00 | Outperform | Low |
| 6/3/2021 | MOR MorphoSys | Upgrade | $20.00 | | Market Perform ➝ Outperform | Medium |
| 6/3/2021 | NPCE NeuroPace | Boost Price Target | $24.00 | $25.00 ➝ $30.00 | Outperform | Low |
| 6/3/2021 | MRK Merck & Co., Inc. | Lower Price Target | $77.00 | $102.00 ➝ $99.00 | Outperform | Medium |
| 6/2/2021 | IMVT Immunovant | Lower Price Target | $11.00 | $38.00 ➝ $17.00 | Outperform | Medium |
| 6/2/2021 | ABT Abbott Laboratories | Lower Price Target | $112.00 | | Market Perform | N/A |
| 6/1/2021 | TALS Talaris Therapeutics | Initiated Coverage | $17.00 | $21.00 | Outperform | Low |
| 6/1/2021 | ZLAB Zai Lab | Boost Price Target | $161.00 | $192.00 ➝ $202.00 | Outperform | Medium |
| 5/31/2021 | PRVB Provention Bio | Reiterated Rating | $8.00 | $16.00 | Buy | Low |
| 5/31/2021 | DBTX Decibel Therapeutics | Reiterated Rating | $8.00 | | Buy | High |
| 5/31/2021 | ICPT Intercept Pharmaceuticals | Reiterated Rating | $20.00 | | Hold | Low |
| 5/31/2021 | CRNX Crinetics Pharmaceuticals | Reiterated Rating | $19.00 | $33.00 | Buy | Medium |
| 5/31/2021 | AXGN AxoGen | Reiterated Rating | $21.00 | $27.00 | Buy | Medium |
| 5/31/2021 | QURE uniQure | Reiterated Rating | $35.00 | | Buy | Low |
| 5/28/2021 | MDT Medtronic | Boost Price Target | $125.00 | $129.00 ➝ $138.00 | Market Perform | Medium |
| 5/27/2021 | RCM R1 RCM | Reiterated Rating | $22.00 | | Buy | High |
| 5/26/2021 | MDRX Allscripts Healthcare Solutions | Boost Price Target | $18.00 | $16.00 ➝ $17.00 | Market Perform | Medium |
| 5/26/2021 | TVTX Travere Therapeutics | Boost Price Target | $15.00 | $27.00 ➝ $35.00 | Outperform | High |
| 5/26/2021 | ITMR Itamar Medical | Lower Price Target | $22.00 | $33.00 ➝ $30.00 | Outperform | Medium |
| 5/26/2021 | ATRC AtriCure | Boost Price Target | $77.00 | $78.00 ➝ $95.00 | Outperform | High |
| 5/26/2021 | A Agilent Technologies | Boost Price Target | $147.00 | $140.00 ➝ $145.00 | Outperform | High |
| 5/25/2021 | HOWL Werewolf Therapeutics | Initiated Coverage | $15.00 | $29.00 | Outperform | High |
| 5/25/2021 | ITOS iTeos Therapeutics | Lower Price Target | $26.00 | $60.00 ➝ $45.00 | Outperform | High |
| 5/25/2021 | INSP Inspire Medical Systems | Reiterated Rating | $190.00 | | Buy | Medium |
| 5/24/2021 | BOLT Bolt Biotherapeutics | Lower Price Target | $16.00 | $37.00 ➝ $33.00 | Outperform | Medium |
| 5/24/2021 | NPCE NeuroPace | Initiated Coverage | $24.00 | $25.00 | Outperform | Medium |
| 5/24/2021 | SBTX Silverback Therapeutics | Lower Price Target | $31.00 | $49.00 ➝ $46.00 | Outperform | High |
| 5/24/2021 | TMCI Treace Medical Concepts | Initiated Coverage | $35.00 | $38.00 | Outperform | Medium |
| 5/24/2021 | HALO Halozyme Therapeutics | Initiated Coverage | $43.00 | $56.00 | Outperform | Low |
| 5/23/2021 | ADAP Adaptimmune Therapeutics | Reiterated Rating | $4.00 | | Hold | Medium |
| 5/23/2021 | RPHM Reneo Pharmaceuticals | Reiterated Rating | $10.00 | $25.00 | Buy | Low |
| 5/23/2021 | IMTX Immatics | Reiterated Rating | $12.00 | $26.00 | Buy | Low |
| 5/23/2021 | GH Guardant Health | Reiterated Rating | $123.00 | | Buy | Low |
| 5/23/2021 | TFX Teleflex | Reiterated Rating | $403.00 | | Buy | Low |
| 5/20/2021 | HTGM HTG Molecular Diagnostics | Lower Price Target | $5.00 | $10.00 | Outperform | Medium |
| 5/20/2021 | DBTX Decibel Therapeutics | Lower Price Target | $8.00 | $26.00 ➝ $18.00 | Outperform | High |
| 5/20/2021 | ITMR Itamar Medical | Lower Price Target | $22.00 | $33.00 ➝ $30.00 | Outperform | High |
| 5/20/2021 | GDRX GoodRx | Lower Price Target | $38.00 | $61.00 ➝ $56.00 | Outperform | Low |
| 5/20/2021 | IONS Ionis Pharmaceuticals | Boost Price Target | $37.00 | $36.00 ➝ $41.00 | Market Perform | Medium |
| 5/20/2021 | MASS 908 Devices | Lower Price Target | $42.00 | $70.00 ➝ $65.00 | Outperform | Low |
| 5/19/2021 | IFRX InflaRx | Reiterated Rating | $3.00 | $6.00 | Buy | Low |
| 5/19/2021 | EOLS Evolus | Reiterated Rating | $13.00 | $18.00 | Buy | Low |
| 5/19/2021 | HOOK Hookipa Pharma | Reiterated Rating | $10.00 | $28.00 | Buy | High |
| 5/19/2021 | RNA Avidity Biosciences | Initiated Coverage | $27.00 | $36.00 | Buy | Medium |
| 5/19/2021 | ETNB 89bio | Reiterated Rating | $19.00 | $62.00 | Buy | Medium |
| 5/19/2021 | ITOS iTeos Therapeutics | Lower Price Target | $26.00 | $60.00 ➝ $45.00 | Outperform | High |
| 5/18/2021 | SYBX Synlogic | Reiterated Rating | $4.00 | $15.00 | Buy | Low |
| 5/18/2021 | GRAY Graybug Vision | Reiterated Rating | $6.00 | $23.00 ➝ $5.00 | Outperform ➝ Market Perform | Low |
| 5/18/2021 | CBAY CymaBay Therapeutics | Reiterated Rating | $5.00 | $10.00 | Buy | Medium |
| 5/18/2021 | STSA Satsuma Pharmaceuticals | Boost Price Target | $6.00 | $4.00 ➝ $5.00 | Market Perform | High |
| 5/18/2021 | EQ Equillium | Reiterated Rating | $6.00 | $18.00 | Buy | High |
| 5/18/2021 | SIEN Sientra | Boost Price Target | $8.00 | $10.00 ➝ $11.00 | Outperform | Low |
| 5/18/2021 | CGEN Compugen | Reiterated Rating | $8.00 | $16.00 | Buy | High |
| 5/18/2021 | SPRB Spruce Biosciences | Reiterated Rating | $12.00 | $35.00 | Buy | High |
| 5/18/2021 | TMCI Treace Medical Concepts | Initiated Coverage | $35.00 | $38.00 | Outperform | High |
| 5/18/2021 | CPSI Computer Programs and Systems | Reiterated Rating | $34.00 | $37.00 | Buy | Low |
| 5/18/2021 | BHVN Biohaven Pharmaceutical | Lower Price Target | $94.00 | $115.00 ➝ $105.00 | Outperform | Medium |
| 5/17/2021 | VCYE Velocity Energy | Lower Price Target | $0.00 | $75.00 ➝ $65.00 | Outperform | N/A |
| 5/17/2021 | ASMB Assembly Biosciences | Lower Price Target | $4.00 | $8.00 ➝ $7.00 | Market Perform | Low |
| 5/17/2021 | TBIO Translate Bio | Boost Price Target | $19.00 | $18.00 ➝ $19.00 | Market Perform | Low |
| 5/17/2021 | XENT Intersect ENT | Lower Price Target | $17.00 | $23.00 ➝ $21.00 | Market Perform | N/A |
| 5/17/2021 | ORGO Organogenesis | Lower Price Target | $17.00 | $27.00 ➝ $26.00 | Outperform | N/A |
| 5/17/2021 | BOLT Bolt Biotherapeutics | Lower Price Target | $16.00 | $37.00 ➝ $33.00 | Outperform | Low |
| 5/17/2021 | NKTR Nektar Therapeutics | Lower Price Target | $17.00 | $21.00 ➝ $20.00 | Market Perform | High |
| 5/17/2021 | NPCE NeuroPace | Initiated Coverage | $24.00 | $25.00 | Outperform | Medium |
| 5/17/2021 | RDUS Radius Health | Boost Price Target | $19.00 | $23.00 ➝ $24.00 | Market Perform | Low |
| 5/17/2021 | RXRX Recursion Pharmaceuticals | Initiated Coverage | $35.00 | $33.00 | Outperform | N/A |
| 5/17/2021 | SBTX Silverback Therapeutics | Lower Price Target | $31.00 | $49.00 ➝ $46.00 | Outperform | High |
| 5/17/2021 | RVMD Revolution Medicines | Lower Price Target | $34.00 | $55.00 ➝ $46.00 | Outperform | N/A |
| 5/17/2021 | VCYT Veracyte | Lower Price Target | $38.00 | $75.00 ➝ $65.00 | Outperform | N/A |
| 5/17/2021 | TRHC Tabula Rasa HealthCare | Boost Price Target | $49.00 | $43.00 ➝ $49.00 | Market Perform | Low |
| 5/17/2021 | HALO Halozyme Therapeutics | Initiated Coverage | $43.00 | $56.00 | Outperform | Low |
| 5/17/2021 | NUAN Nuance Communications | Lower Price Target | $55.00 | $60.00 ➝ $56.00 | Outperform | N/A |
| 5/17/2021 | BNTX BioNTech | Boost Price Target | $215.00 | $118.00 ➝ $159.00 | Market Perform | N/A |
| 5/14/2021 | TTOO T2 Biosystems | Reiterated Rating | $1.00 | $3.00 | Buy | Medium |
| 5/14/2021 | HTGM HTG Molecular Diagnostics | Lower Price Target | $5.00 | $10.00 | Outperform | High |
| 5/14/2021 | DBTX Decibel Therapeutics | Lower Price Target | $8.00 | $26.00 ➝ $18.00 | Outperform | High |
| 5/14/2021 | GDRX GoodRx | Lower Price Target | $38.00 | $61.00 ➝ $56.00 | Outperform | High |
| 5/14/2021 | MASS 908 Devices | Lower Price Target | $42.00 | $70.00 ➝ $65.00 | Outperform | High |
| 5/14/2021 | IONS Ionis Pharmaceuticals | Boost Price Target | $37.00 | $36.00 ➝ $41.00 | Market Perform | Medium |
